Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

Sirtuin 3 attenuates amyloid-β induced neuronal hypometabolism

First author:Yin Junxiang,Li Shiping

Corresponding author:Shi Jiong

Sirtuin 3 Alzheimer’s disease cerebral hypometabo

essential_information

2018-10-23

Published articles

Journal:Aging

Publication type: Article

IF(IF): 5.515

PMID: 30362958 Link To Pubmed Full text Download

Background And Purpose

Method

We used expression profiling and weighted gene co-expression network analysis (WGCNA) to analyze cortical neurons from a transgenic mouse model of AD (APPSwInd). Based on WGCNA results, we measured NAD+ level, NAD+/ NADH ratio, Sirt3 protein level and its deacetylation activity, and ATP production across both in vivo and in vitro models. To investigate the effect of Sirt3 on amyloid-β (Aβ)-induced mitochondria damage, we knocked down and over-expressed Sirt3 in hippocampal cells. WGCNA revealed Sirt3 as a key player in Aβ-related hypometabolism.

Conclusion

As a result, learning and memory performance were impaired in 9-month-old APP mice compared to wild type controls. Using hippocampal HT22 cells model, Sirt3 overexpression increased Sirt3 deacetylation activity, rescued mitochondria function, and salvaged ATP production, which were damaged by Aβ. Sirt3 plays an important role in regulating Aβ-induced cerebral hypometabolism. This study suggests a potential direction for AD therapy.

Main results

In APP mice, the NAD+ level, NAD+/ NADH ratio, Sirt3 protein level and activity, and ATP production were all reduced compared to the control.